NYSE:DLB - Dolby Laboratories Stock Price, Price Target & More

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories declared a quarterly dividend on Tuesday, April 24th. Stockholders of record on Monday, May 7th will be given a dividend of $0.16 per share on Wednesday, May 16th. This represents a $0.64 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend is Friday, May 4th. View Dolby Laboratories' Dividend History.

Dolby Laboratories announced that its Board of Directors has initiated a share buyback plan on Sunday, April 9th 2017, which authorizes the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's board believes its shares are undervalued.

Dolby Laboratories, Inc. (NYSE:DLB) issued its earnings results on Tuesday, April, 24th. The electronics maker reported $0.78 earnings per share for the quarter, topping analysts' consensus estimates of $0.64 by $0.14. The electronics maker had revenue of $301.36 million for the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a net margin of 7.64% and a return on equity of 12.73%. The firm's quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.63 EPS. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories updated its third quarter earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $0.78-0.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.97. The company issued revenue guidance of $310-320 million, compared to the consensus revenue estimate of $330.43 million.

5 brokers have issued twelve-month price objectives for Dolby Laboratories' shares. Their predictions range from $52.00 to $78.00. On average, they expect Dolby Laboratories' share price to reach $65.20 in the next twelve months. View Analyst Ratings for Dolby Laboratories.

Some companies that are related to Dolby Laboratories include InterDigital (IDCC), TiVo (TIVO), RPX (RPXC), Acacia Research (ACTG), Quarterhill (QTRH), Digital Turbine (APPS), Joint (JYNT), Liberty Tax (TAX), Finjan (FNJN), MGT Capital Investments (MGTI), Copytele (ITUS), XCel Brands (XELB), Marathon Patent Group (MARA), Research Frontiers (REFR) and ARC Group (ARCK).

Media headlines about DLB stock have been trending somewhat negative recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Dolby Laboratories earned a coverage optimism score of -0.06 on Accern's scale. They also gave news articles about the electronics maker an impact score of 46.77 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Dolby Laboratories' stock is owned by many different of institutional and retail investors. Top institutional shareholders include DOLBY DAGMAR (41.00%), DOLBY DAGMAR (40.60%), BlackRock Inc. (2.87%), American Century Companies Inc. (1.44%), Allianz Asset Management GmbH (1.12%) and Allianz Asset Management GmbH (1.12%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Michael Bergeron, N William Jasper, Jr, Nicholas Donatiello Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Schroder Investment Management Group, American Century Companies Inc., JPMorgan Chase & Co., OppenheimerFunds Inc., UBS Group AG, BlackRock Inc. and Polar Asset Management Partners Inc.. Company insiders that have sold Dolby Laboratories company stock in the last year include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.

DLB stock was purchased by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Allianz Asset Management GmbH, Summit Trail Advisors LLC, DekaBank Deutsche Girozentrale, Columbus Circle Investors, Fiera Capital Corp, Blair William & Co. IL and Wells Fargo & Company MN. View Insider Buying and Selling for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $65.12.

Dolby Laboratories has a market capitalization of $6.81 billion and generates $1.08 billion in revenue each year. The electronics maker earns $201.80 million in net income (profit) each year or $2.20 on an earnings per share basis. Dolby Laboratories employs 2,122 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]